| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |